Page 3 - Expansion Study News Today

5 of 5 Overall Attendance: 100% Other Public Boards N/A ... | April 19, 2023

Strong outlook with multi-year production guidance increased, capital guidance maintained, and all-in sustaining costs expected to decrease 18% over the...

Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib (MK-1026) – as well as KEYTRUDA® (pembrolizumab) in multiple blood cancersRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Ca...

01.12.2022 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from clinical trials and real-world studies at the upcoming 64th American Society of Hematology (ASH) Annual Meeting from Dec. ...

11.10.2022 - - NEObody technology platform enables dynamic targeting of a distinct epitope of CTLA-4 for enhanced safety and efficacy -        - Data from phase 1b/2 studies in heavily pre-treated patients showcase differentiated safety profile of ... Seite 1

/PRNewswire/ - Copper Mountain Mining Corporation (TSX: CMMC) (ASX: C6C) (the "Company" or "Copper Mountain") is pleased to announce an updated Mineral...

Resource veteran takes reins as Magnetite moves to develop Razorback

Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination in a Phase 1/2 Study for the Treatment of Patients with Solid Tumors Who Were Resistant to Prior Anti-PD-1/PD-L1 Therapy - read this article along with other careers information, tips and advice on BioSpace

Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE -

Alamos Gold owns Island Gold